p3 primary cell nucleofector buffer (Lonza)
Lonza is a verified supplier 
Lonza manufactures this product 
90
Structured Review
Lonza
p3 primary cell nucleofector buffer
P3 Primary Cell Nucleofector Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p3+primary+buffer/4d+nucleofector/pm40570854-740-8-7
Average 90 stars, based on 1 article reviews
P3 Primary Cell Nucleofector Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p3+primary+buffer/4d+nucleofector/pm40570854-740-8-7
Average 90 stars, based on 1 article reviews
p3 primary cell nucleofector buffer - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene Article Snippet: Briefly, approximately 1 × 10 6 single cells were resuspended in P3 primary buffer ( Article Title: Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene. Article Snippet: Mutations in the FUS (fused in sarcoma) gene are implicated in the neurodegenerative disease amyotrophic lateral sclerosis (ALS).. However, the pathophysiology underlying these mutations remains elusive.. In this study, we created two induced pluripotent stem cell (iPSC) lines through genetic modification of a healthy hiPSC line (WTC11, UCSFi001-A). Article Title: Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene. Article Snippet: Briefly, approximately 1 × 106 single cells were resuspended in P3 primary buffer ( Mutagenesis:Article Title: Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene Article Snippet: .. To begin, about 1 million single cells were suspended in P3 primary buffer ( Article Title: Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene Article Snippet: .. Briefly, approximately 1 × 10 6 single cells were resuspended in P3 primary buffer ( Article Title: Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene. Article Snippet: Mutations in the RNA-binding protein FUS (fused in sarcoma) are linked to amyotrophic lateral sclerosis (ALS), but the pathogenesis is not fully understood.. For modeling ALS, here we generated two induced pluripotent stem cell (iPSC) lines carrying the heterozygous and homozygous R521G (c.1561C > G) mutation in the FUS gene via genetic modification of a healthy hiPSC line (WTC11, UCSFi001-A).. Both lines show normal stem cell morphology and karyotype, express pluripotent markers, and can differentiate into three germ layers, providing a valuable resource in determining the pathological mechanisms underlying the FUS mutation of R521G in ALS. Suspension:Article Title: TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells. Article Snippet: .. Two million cells/condition were resuspended in Article Title: TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells Article Snippet: .. Two million cells/condition were resuspended in |